vs

Side-by-side financial comparison of Global Net Lease, Inc. (GNL) and PUMA BIOTECHNOLOGY, INC. (PBYI). Click either name above to swap in a different company.

Global Net Lease, Inc. is the larger business by last-quarter revenue ($117.0M vs $75.5M, roughly 1.6× PUMA BIOTECHNOLOGY, INC.). On growth, PUMA BIOTECHNOLOGY, INC. posted the faster year-over-year revenue change (27.7% vs -15.1%). Over the past eight quarters, PUMA BIOTECHNOLOGY, INC.'s revenue compounded faster (31.3% CAGR vs -11.1%).

Global Net Lease, Inc. is a publicly traded real estate investment trust that acquires, owns and manages a diversified portfolio of commercial real estate assets under long-term net lease contracts. Its property portfolio spans North America and Europe, covering industrial, office, retail and other key sectors, serving tenants across multiple industries to deliver consistent long-term returns for shareholders.

Puma Biotechnology is a publicly traded biopharmaceutical company headquartered in Los Angeles, CA.

GNL vs PBYI — Head-to-Head

Bigger by revenue
GNL
GNL
1.6× larger
GNL
$117.0M
$75.5M
PBYI
Growing faster (revenue YoY)
PBYI
PBYI
+42.8% gap
PBYI
27.7%
-15.1%
GNL
Faster 2-yr revenue CAGR
PBYI
PBYI
Annualised
PBYI
31.3%
-11.1%
GNL

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
GNL
GNL
PBYI
PBYI
Revenue
$117.0M
$75.5M
Net Profit
$48.2M
Gross Margin
69.3%
Operating Margin
94.7%
22.7%
Net Margin
41.2%
Revenue YoY
-15.1%
27.7%
Net Profit YoY
838.7%
EPS (diluted)
$0.14
$0.26

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
GNL
GNL
PBYI
PBYI
Q4 25
$117.0M
$75.5M
Q3 25
$121.0M
$54.5M
Q2 25
$124.9M
$52.4M
Q1 25
$132.4M
$46.0M
Q4 24
$137.8M
$59.1M
Q3 24
$138.7M
$80.5M
Q2 24
$145.5M
$47.1M
Q1 24
$147.9M
$43.8M
Net Profit
GNL
GNL
PBYI
PBYI
Q4 25
$48.2M
Q3 25
$-60.1M
$8.8M
Q2 25
$-24.1M
$5.9M
Q1 25
$-189.4M
$3.0M
Q4 24
$-6.5M
Q3 24
$-65.6M
$20.3M
Q2 24
$-35.7M
$-4.5M
Q1 24
$-23.8M
$-4.8M
Gross Margin
GNL
GNL
PBYI
PBYI
Q4 25
69.3%
Q3 25
77.7%
Q2 25
76.5%
Q1 25
77.1%
Q4 24
76.4%
Q3 24
63.9%
Q2 24
77.4%
Q1 24
75.5%
Operating Margin
GNL
GNL
PBYI
PBYI
Q4 25
94.7%
22.7%
Q3 25
-11.7%
17.6%
Q2 25
33.9%
12.7%
Q1 25
-21.1%
8.7%
Q4 24
40.8%
22.6%
Q3 24
9.3%
27.4%
Q2 24
42.6%
-4.6%
Q1 24
38.6%
-5.3%
Net Margin
GNL
GNL
PBYI
PBYI
Q4 25
41.2%
Q3 25
-49.7%
16.2%
Q2 25
-19.3%
11.2%
Q1 25
-143.0%
6.5%
Q4 24
-4.7%
Q3 24
-47.3%
25.2%
Q2 24
-24.5%
-9.6%
Q1 24
-16.1%
-11.0%
EPS (diluted)
GNL
GNL
PBYI
PBYI
Q4 25
$0.14
$0.26
Q3 25
$-0.32
$0.17
Q2 25
$-0.16
$0.12
Q1 25
$-0.87
$0.06
Q4 24
$-0.08
$0.40
Q3 24
$-0.33
$0.41
Q2 24
$-0.20
$-0.09
Q1 24
$-0.15
$-0.10

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
GNL
GNL
PBYI
PBYI
Cash + ST InvestmentsLiquidity on hand
$180.1M
$97.5M
Total DebtLower is stronger
$22.7M
Stockholders' EquityBook value
$1.7B
$130.3M
Total Assets
$4.3B
$216.3M
Debt / EquityLower = less leverage
0.17×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
GNL
GNL
PBYI
PBYI
Q4 25
$180.1M
$97.5M
Q3 25
$165.1M
$94.4M
Q2 25
$144.8M
$96.0M
Q1 25
$147.0M
$93.2M
Q4 24
$159.7M
$101.0M
Q3 24
$127.2M
$96.7M
Q2 24
$122.2M
$96.8M
Q1 24
$131.9M
$107.2M
Total Debt
GNL
GNL
PBYI
PBYI
Q4 25
$22.7M
Q3 25
$34.0M
Q2 25
$45.3M
Q1 25
$56.7M
Q4 24
$68.0M
Q3 24
$79.3M
Q2 24
$90.7M
Q1 24
$102.0M
Stockholders' Equity
GNL
GNL
PBYI
PBYI
Q4 25
$1.7B
$130.3M
Q3 25
$1.7B
$115.3M
Q2 25
$1.8B
$104.7M
Q1 25
$1.9B
$97.1M
Q4 24
$2.2B
$92.1M
Q3 24
$2.3B
$71.1M
Q2 24
$2.4B
$48.5M
Q1 24
$2.5B
$51.0M
Total Assets
GNL
GNL
PBYI
PBYI
Q4 25
$4.3B
$216.3M
Q3 25
$4.8B
$202.9M
Q2 25
$5.0B
$194.9M
Q1 25
$5.8B
$196.2M
Q4 24
$7.0B
$213.3M
Q3 24
$7.3B
$220.7M
Q2 24
$7.6B
$205.0M
Q1 24
$8.0B
$214.1M
Debt / Equity
GNL
GNL
PBYI
PBYI
Q4 25
0.17×
Q3 25
0.30×
Q2 25
0.43×
Q1 25
0.58×
Q4 24
0.74×
Q3 24
1.12×
Q2 24
1.87×
Q1 24
2.00×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
GNL
GNL
PBYI
PBYI
Operating Cash FlowLast quarter
$222.8M
$14.4M
Free Cash FlowOCF − Capex
$14.4M
FCF MarginFCF / Revenue
19.1%
Capex IntensityCapex / Revenue
0.0%
Cash ConversionOCF / Net Profit
4.62×
TTM Free Cash FlowTrailing 4 quarters
$41.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
GNL
GNL
PBYI
PBYI
Q4 25
$222.8M
$14.4M
Q3 25
$56.0M
$9.7M
Q2 25
$52.0M
$14.1M
Q1 25
$59.2M
$3.6M
Q4 24
$299.5M
$15.6M
Q3 24
$62.1M
$11.0M
Q2 24
$70.4M
$1.0M
Q1 24
$92.2M
$11.2M
Free Cash Flow
GNL
GNL
PBYI
PBYI
Q4 25
$14.4M
Q3 25
$9.7M
Q2 25
$14.1M
Q1 25
$3.6M
Q4 24
$15.6M
Q3 24
$11.0M
Q2 24
$1.0M
Q1 24
FCF Margin
GNL
GNL
PBYI
PBYI
Q4 25
19.1%
Q3 25
17.7%
Q2 25
26.8%
Q1 25
7.7%
Q4 24
26.4%
Q3 24
13.7%
Q2 24
2.1%
Q1 24
Capex Intensity
GNL
GNL
PBYI
PBYI
Q4 25
0.0%
Q3 25
0.0%
Q2 25
0.0%
Q1 25
0.1%
Q4 24
0.0%
Q3 24
0.0%
Q2 24
0.0%
Q1 24
0.0%
Cash Conversion
GNL
GNL
PBYI
PBYI
Q4 25
4.62×
Q3 25
1.10×
Q2 25
2.41×
Q1 25
1.21×
Q4 24
Q3 24
0.54×
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

GNL
GNL

Industrial And Distribution Segment$56.0M48%
Office Segment$30.8M26%
Single Tenant Retail Segment$30.2M26%

PBYI
PBYI

Segment breakdown not available.

Related Comparisons